Biological activities and molecular docking of brassinosteroids 24-norcholane type analogs
MetadataShow full item record
The quest and design of new brassinosteroids analogs is a matter of current interest. Herein, the effect of short alkyl side chains and the configuration at C22 on the growth-promoting activity of a series of new brassinosteroid 24-norcholan-type analogs have been evaluated by the rice leaf inclination test using brassinolide as positive control. The highest activities were found for triol 3 with a C22(S) configuration and monobenzoylated derivatives. A docking study of these compounds into the active site of the Brassinosteroid Insensitive 1(BRI1)–ligand–BRI1-Associated Receptor Kinase 1 (BAK1) complex was performed using AutoDock Vina, and protein–ligand contacts were analyzed using LigPlot+ . The results suggest that the hydrophobic interactions of ligands with the receptor BRI1LRR and hydrogen bonding with BAK1 in the complex are important for ligand recognition. For monobenzoylated derivatives, the absence of the hydrophobic end in the alkyl chain seems to be compensated by the benzoyl group. Thus, it would be interesting to determine if this result depends on the nature of the substituent group. Finally, mixtures of S/R triols 3/4 exhibit activities that are comparable or even better than those found for brassinolide. Thus, these compounds are potential candidates for application in agriculture to improve the growth and yield of plants against various types of biotic and abiotic stress. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Showing items related by title, author, creator and subject.
Synthesis of five known brassinosteroid analogs from hyodeoxycholic acid and their activities as plant-growth regulators (2020) Duran M.I.; González C.; Acosta A.; Olea A.F.; Díaz K.; Espinoza L. (MDPI AG, 2017)
Inhibition of C. albicans dimorphic switch by cobalt(II) complexes with ligands derived from pyrazoles and dinitrobenzoate: Synthesis, characterization and biological activity (2020) Fonseca D.; Leal-Pinto S.M.; Roa-Cordero M.V.; Vargas J.D.; Moreno-Moreno E.M.; Macías M.A.; Suescun L.; Muñoz-Castro Á.; Hurtado J.J. (MDPI AG, 2019)
Targeting α -(1,4)-glucosidase in diabetes mellitus type 2: The role of new synthetic coumarins as potent inhibitors (2020) Figueroa-Benavides C.; Matos M.J.; Peñaloza-Amion M.; Veas R.; Valenzuela-Barra G.; Zapata G.; Delogu G.; Uriarte E.; Santana L.; Olea-Azar C.; ... (Bentham Science Publishers B.V., 2018)